House Committee Hears Criticisms of FDA Devices Review Process | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The House of Representatives committee that serves as a government watchdog held a hearing yesterday focused on whether an overstretched Food and Drug Administration is slowing down the advance of new medical devices, hurting the growth of industry, and making venture investors skittish about backing medical device start-ups.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.